Shaperon Stock

Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.

Sign up today and learn more about Shaperon Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Shaperon Stock

Funding History

October 2020$26.0B

Management

CEO & Founder

Seung-Yong Seong

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo